yttrium Y90 ibritumomab tiuxetan
- yttrium Y90 ibritumomab tiuxetan
An anticancer drug that is a combination of a monoclonal antibody and a radioisotope (yttrium-90). Monoclonal antibodies are made in the laboratory and can locate and bind to cancer cells. Also called IDEC-Y2B8.
English dictionary of cancer terms .
2015.
Look at other dictionaries:
Yttrium (90Y) clivatuzumab tetraxetan — Yttrium (90Y) clivatuzumab tetraxetan? Monoclonal antibody Type Whole antibody Source Humanized (from mouse) Target MUC1 Clinical data Pregnancy cat. ? … Wikipedia
IDEC-Y2B8 — An anticancer drug that is a combination of a monoclonal antibody and a radioisotope (yttrium 90). Monoclonal antibodies are made in the laboratory and can locate and bind to cancer cells. Also called yttrium Y90 ibritumomab tiuxetan … English dictionary of cancer terms
